Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	145.9	357.59	261.67	284.28	141.18	112.63
Short-Term Investments	-	0.73	0.69	0.8	1.06	39.36
Trading Asset Securities	0.57	0.54	0.64	5.16	5.12	-
Cash & Short-Term Investments	146.47	358.86	263	290.24	147.36	151.99
Cash Growth	-13.69%	36.45%	-9.38%	96.96%	-3.05%	-40.65%
Accounts Receivable	1,007	586.3	443.52	332.13	352.36	366.9
Other Receivables	3.25	34.66	29.77	22.68	28.59	20.58
Receivables	1,028	620.96	473.29	360.62	389.27	404.93
Inventory	275.05	248.21	270.88	233.92	131.86	135.17
Prepaid Expenses	38.77	5.44	4.57	3.99	4.52	3.09
Other Current Assets	-	7.54	16.95	17.93	15.08	4.48
Total Current Assets	1,488	1,241	1,029	906.7	688.08	699.67
Property, Plant & Equipment	815.46	718.48	673.93	698.3	705.05	713.87
Long-Term Investments	64.27	68.81	57.49	36.11	0.25	3.97
Other Intangible Assets	25.32	17.27	11.53	13.05	14.43	14.79
Total Assets	2,393	2,046	1,772	1,654	1,408	1,432

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	397.29	40.79	42.61	67.98	39.79	41.81
Accrued Expenses	1	117.15	104.19	66.75	51.98	59.55
Current Portion of Leases	3.5	3.24	0.26	0.25	0.24	0.25
Current Income Taxes Payable	28.31	35.06	28.8	25.51	17.72	19.74
Current Unearned Revenue	-	1.5	2.14	3.77	-	-
Other Current Liabilities	-	26.81	23.76	15.72	17.27	17.01
Total Current Liabilities	430.1	224.55	201.76	179.97	126.99	138.36
Long-Term Leases	33.65	13.19	1.83	2.16	2.4	1.72
Pension & Post-Retirement Benefits	101.66	91.05	77.43	67.71	62.16	60.58
Total Liabilities	565.41	328.79	281.03	249.84	191.55	200.66

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	700	700	700	700	700	100
Retained Earnings	1,290	1,168	950.81	811.99	591.35	1,170
Comprehensive Income & Other	-162.39	-151.04	-160.21	-107.66	-75.08	-37.88
Total Common Equity	1,827	1,717	1,491	1,404	1,216	1,232
Shareholders' Equity	1,827	1,717	1,491	1,404	1,216	1,232
Total Liabilities & Equity	2,393	2,046	1,772	1,654	1,408	1,432

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	37.15	16.43	2.09	2.4	2.64	1.97
Net Cash (Debt)	109.32	342.42	260.91	287.84	144.72	150.03
Net Cash Growth	-33.99%	31.24%	-9.36%	98.89%	-3.53%	-5.55%
Net Cash Per Share	1.56	4.89	3.73	4.11	2.07	15.00
Filing Date Shares Outstanding	70	70	70	70	70	10
Total Common Shares Outstanding	70	70	70	70	70	10
Working Capital	1,058	1,016	826.92	726.73	561.09	561.3
Book Value Per Share	26.11	24.53	21.29	20.06	17.38	123.16
Tangible Book Value	1,802	1,699	1,479	1,391	1,202	1,217
Tangible Book Value Per Share	25.74	24.28	21.13	19.88	17.17	121.68
Land	58.55	58.68	58.56	59.73	60.46	62.59
Buildings	346.95	277.25	271.46	224.31	177.98	176.67
Machinery	823.78	784.17	719.15	564.16	515.41	510.48
Construction In Progress	42.84	45.53	59.53	252.89	329.94	325.12

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error